Credit Suisse Starts Kura Oncology (KURA) at Outperform
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Price: $11.89 +1.54%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Martin Auster initiates coverage on Kura Oncology (NASDAQ: KURA) with a Outperform rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Kura Oncology click here. For more ratings news on Kura Oncology click here.
Shares of Kura Oncology closed at $16.72 yesterday.
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
- BMO Capital Starts Broadcom Limited (AVGO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
